Form 8-K - Current report:
SEC Accession No. 0001193125-23-176628
Filing Date
2023-06-28
Accepted
2023-06-28 06:07:29
Documents
14
Period of Report
2023-06-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d526740d8k.htm   iXBRL 8-K 37636
2 EX-99.1 d526740dex991.htm EX-99.1 21931
6 GRAPHIC g526740g0628025609561.jpg GRAPHIC 3811
  Complete submission text file 0001193125-23-176628.txt   199892

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA meip-20230627.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230627_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230627_pre.xml EX-101.PRE 11265
8 EXTRACTED XBRL INSTANCE DOCUMENT d526740d8k_htm.xml XML 3341
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 231049114
SIC: 2834 Pharmaceutical Preparations